Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Neoplasm × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 104 Carcinoma, Non-Small-Cell Lung 54 Lung Neoplasms 24 Hodgkin Disease 14 Lymphoma 10 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 7 Neoplasms 7 Recurrence 6 Neoplasm Metastasis 6 Small Cell Lung Carcinoma 5 Lymphoma, Large B-Cell, Diffuse 5 Sarcoma 4 Rhabdomyosarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Breast Neoplasms, Male 4 Ovarian Neoplasms 3 NSCLC 3 Multiple Myeloma 3 Mesothelioma, Malignant 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Esophageal Squamous Cell Carcinoma 3 Burkitt Lymphoma 3 Brain Neoplasms 3

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡